Home Cart 0 Sign in  
X

[ CAS No. 829-35-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 829-35-6
Chemical Structure| 829-35-6
Chemical Structure| 829-35-6
Structure of 829-35-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 829-35-6 ]

Related Doc. of [ 829-35-6 ]

Alternatived Products of [ 829-35-6 ]

Product Details of [ 829-35-6 ]

CAS No. :829-35-6 MDL No. :MFCD00491615
Formula : C9H8N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :GYESXRJGLIKNAM-UHFFFAOYSA-N
M.W : 176.17 Pubchem ID :766687
Synonyms :

Calculated chemistry of [ 829-35-6 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.11
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.23
TPSA : 48.15 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.47 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.08
Log Po/w (XLOGP3) : 1.28
Log Po/w (WLOGP) : 1.75
Log Po/w (MLOGP) : 1.08
Log Po/w (SILICOS-IT) : 1.9
Consensus Log Po/w : 1.62

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.23
Solubility : 1.03 mg/ml ; 0.00585 mol/l
Class : Soluble
Log S (Ali) : -1.89
Solubility : 2.27 mg/ml ; 0.0129 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.51
Solubility : 0.0547 mg/ml ; 0.00031 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.92

Safety of [ 829-35-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 829-35-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 829-35-6 ]
  • Downstream synthetic route of [ 829-35-6 ]

[ 829-35-6 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 3290-99-1 ]
  • [ 122-51-0 ]
  • [ 829-35-6 ]
YieldReaction ConditionsOperation in experiment
100% With ammonium chloride In ethanol for 0.5 h; Reflux General procedure: To asolution of hydrazide (0.73 mmol) in 10 mL of anhydrous ethanol, added triethyl orthoester (0.81 mmol) and ammonium chloride (0.219 mmol). The solution was stirred and heated to reflux until it complete (0.5-18 h). The reaction mass was cooled to room temperature and concentrated under vacuum. The crude product was made into slurry in a mixture of hexanes and ether (3:1), filtered,washed with deionized water or purified by column chromatography.
92% at 100 - 110℃; for 12 h; To a mixture of 3 (18.0 g, 0.1083 mol) and triethyl orthoformate (80.3 g, 0.541 mol) was heated to 100-110 °C and maintained for 12 h. The reaction completion was monitored by TLC. The reaction mixture was cooled to room temperature and concentrated to syrup. Traces triethyl orthoformate was removed by azeotropic distillation with toluene. The residue was purified by column chromatography on silica gel using eluent 0-5percent ethyl acetate in petroleum ether. The title compound was yielded as pale yellow liquid (Yield: 17.55 g, 92percent).
Reference: [1] Tetrahedron Letters, 2014, vol. 55, # 50, p. 6776 - 6778
[2] Organic Letters, 2018, vol. 20, # 19, p. 6027 - 6032
[3] Angewandte Chemie - International Edition, 2011, vol. 50, # 48, p. 11511 - 11515
[4] Journal of the American Chemical Society, 2016, vol. 138, # 38, p. 12605 - 12614
[5] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 276 - 283
[6] Tetrahedron Letters, 2008, vol. 49, # 5, p. 879 - 883
[7] Journal of Organic Chemistry, 2009, vol. 74, # 16, p. 6410 - 6413
[8] Chemistry - A European Journal, 2011, vol. 17, # 30, p. 8294 - 8298
[9] Angewandte Chemie - International Edition, 2012, vol. 51, # 19, p. 4666 - 4670
[10] Zhurnal Obshchei Khimii, 1959, vol. 29, p. 2027,2030; engl. Ausg. S. 1996, 1998
[11] Organic Letters, 2010, vol. 12, # 15, p. 3567 - 3569
[12] Tetrahedron, 2012, vol. 68, # 1, p. 300 - 305
[13] Magnetic Resonance in Chemistry, 2011, vol. 49, # 10, p. 648 - 654
[14] European Journal of Organic Chemistry, 2012, # 3, p. 471 - 474
[15] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 92, p. 11307 - 11309,3
[16] Tetrahedron, 2013, vol. 69, # 9, p. 2220 - 2225
  • 2
  • [ 3290-99-1 ]
  • [ 829-35-6 ]
YieldReaction ConditionsOperation in experiment
67% With trifluoroacetic acid In toluene at 130℃; for 12 h; General procedure: A 25 mL pressure tube was charged with arylhydrazide 1 (0.5 mmol), TFBen (53 mg, 0.25 mmol, white solid, mp 57.2-58.5 °C), TFA (38 μL, 1.0 equiv), and toluene (4 mL). The tube was then heated by stirring the contents at 130 °C for 12 h. Afterwards, the mixture was cooled to r.t., quenched with sat. aq NaHCO3 (3 mL), and extracted with EtOAc (3 4 mL). The combined organic layers were dried (anhyd Na2SO4), filtered, and concentrated under reduced pressure. The pure product 2 was obtained after purification by column chromatography (EtOAc/ pentane 1:3).
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 16, p. 3238 - 3242
  • 3
  • [ 3290-99-1 ]
  • [ 149-73-5 ]
  • [ 829-35-6 ]
YieldReaction ConditionsOperation in experiment
96% With Al3+-K10 montmorillonite clay In neat (no solvent) at 55℃; for 0.25 h; Microwave irradiation General procedure: A 5 mL microwave vial was charged with acidhydrazide (100 mg, 1 eq), trimethyl orthoester (2 eq) and Al3+-K10 clay (75 mg). The resulting mixture was kept under microwave irradiation maintaining the temperature at 55 °C for 15 min (Microwave irradiations were performed on CEM-discover model No. 908010). The reaction was monitored by TLC. After completion of the reaction, reaction mixture was diluted with ethyl acetate stirred well, filtered, washed well with ethyl acetate. Filtrate was evaporated under reduced pressure to obtain highly pure product. In some cases, products were purified by column chromatography using 60-120 mesh silica with 20-100 percent ethyl acetate in pet ether as eluting solvents. The catalyst recovered by filtration was reused for another 5 more times.
Reference: [1] Tetrahedron Letters, 2014, vol. 55, # 27, p. 3678 - 3682
[2] Journal of Medicinal Chemistry, 2001, vol. 44, # 8, p. 1268 - 1285
[3] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 11, p. 2909 - 2914
  • 4
  • [ 3290-99-1 ]
  • [ 100-06-1 ]
  • [ 829-35-6 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 12, p. 2960 - 2963
  • 5
  • [ 3290-99-1 ]
  • [ 536-74-3 ]
  • [ 829-35-6 ]
Reference: [1] Journal of Organic Chemistry, 2016, vol. 81, # 15, p. 6820 - 6825
  • 6
  • [ 292638-84-7 ]
  • [ 3290-99-1 ]
  • [ 829-35-6 ]
Reference: [1] Journal of Organic Chemistry, 2016, vol. 81, # 15, p. 6820 - 6825
  • 7
  • [ 121-98-2 ]
  • [ 829-35-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 8, p. 1268 - 1285
[2] Magnetic Resonance in Chemistry, 2011, vol. 49, # 10, p. 648 - 654
[3] Angewandte Chemie - International Edition, 2012, vol. 51, # 19, p. 4666 - 4670
[4] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 92, p. 11307 - 11309,3
  • 8
  • [ 100-09-4 ]
  • [ 829-35-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 19, p. 4666 - 4670
[2] Chemical Communications (Cambridge, United Kingdom), 2012, vol. 48, # 92, p. 11307 - 11309,3
[3] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 276 - 283
  • 9
  • [ 94-30-4 ]
  • [ 829-35-6 ]
Reference: [1] Chemistry - A European Journal, 2011, vol. 17, # 30, p. 8294 - 8298
[2] European Journal of Medicinal Chemistry, 2013, vol. 65, p. 276 - 283
  • 10
  • [ 121-98-2 ]
  • [ 149-73-5 ]
  • [ 829-35-6 ]
Reference: [1] Magnetic Resonance in Chemistry, 2003, vol. 41, # 9, p. 689 - 692
  • 11
  • [ 74-83-9 ]
  • [ 829-35-6 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1966, p. 376 - 381
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 829-35-6 ]

Aryls

Chemical Structure| 51039-53-3

[ 51039-53-3 ]

2-Bromo-5-phenyl-1,3,4-oxadiazole

Similarity: 0.77

Chemical Structure| 99367-44-9

[ 99367-44-9 ]

Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate

Similarity: 0.76

Chemical Structure| 1483-31-4

[ 1483-31-4 ]

2-Chloro-5-phenyl-1,3,4-oxadiazole

Similarity: 0.73

Chemical Structure| 1612-76-6

[ 1612-76-6 ]

5-Phenyl-1,3,4-oxadiazol-2-amine

Similarity: 0.73

Chemical Structure| 959-36-4

[ 959-36-4 ]

2,2'-(Hydrazine-1,2-diylidenebis(methanylylidene))diphenol

Similarity: 0.67

Ethers

Chemical Structure| 99367-44-9

[ 99367-44-9 ]

Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate

Similarity: 0.76

Chemical Structure| 91063-19-3

[ 91063-19-3 ]

3-(Benzyloxy)-6-chloropyridazine

Similarity: 0.62

Chemical Structure| 121041-41-6

[ 121041-41-6 ]

6-(4-Methoxyphenoxy)pyridazin-3-amine

Similarity: 0.61

Chemical Structure| 2096-20-0

[ 2096-20-0 ]

3,5-Dimethoxypyridazine

Similarity: 0.58

Chemical Structure| 17644-83-6

[ 17644-83-6 ]

3-Methoxy-6-methylpyridazine

Similarity: 0.58

Related Parent Nucleus of
[ 829-35-6 ]

Oxadiazoles

Chemical Structure| 51039-53-3

[ 51039-53-3 ]

2-Bromo-5-phenyl-1,3,4-oxadiazole

Similarity: 0.77

Chemical Structure| 99367-44-9

[ 99367-44-9 ]

Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate

Similarity: 0.76

Chemical Structure| 1483-31-4

[ 1483-31-4 ]

2-Chloro-5-phenyl-1,3,4-oxadiazole

Similarity: 0.73

Chemical Structure| 1612-76-6

[ 1612-76-6 ]

5-Phenyl-1,3,4-oxadiazol-2-amine

Similarity: 0.73

Chemical Structure| 3004-42-0

[ 3004-42-0 ]

5-Phenyl-1,3,4-oxadiazole-2(3H)-thione

Similarity: 0.57